Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk B | Copenhagen | Healthcare | Pharmaceuticals | DKK 3.88T | 44x | 0.95 | DKK 873.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
H Lundbeck AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 39.57B | 14.8x | 13.32 | DKK 35.95 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
H Lundbeck B | Copenhagen | Healthcare | Pharmaceuticals | DKK 39.57B | 14.8x | 13.3 | DKK 41.54 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
ALK-Abello B | Copenhagen | Healthcare | Pharmaceuticals | DKK 33.27B | 58.6x | 0.87 | DKK 149.70 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bavarian Nordic | Copenhagen | Healthcare | Pharmaceuticals | DKK 14.06B | 14.3x | 0.07 | DKK 181 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Stenocare AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 72.33M | -4.8x | -0.12 | DKK 3.64 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |